Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

COPART INC (CPRT)

  • Business News
  • June 29, 2026, 13:00 UTC
  • 2
  • 1 comments

Copart Announces CEO Transition

Market reaction Comment Full text

DOMO, INC. (DOMO)

  • Business News
  • June 29, 2026, 12:57 UTC
  • 3
  • 1 comments

Domo Recognized as “One to Watch” in Snowflake’s Modern Marketing Data Stack Report

Market reaction Comment Full text

MCGRAW HILL, INC. (MH)

  • Business News
  • June 29, 2026, 12:57 UTC
  • 3
  • 1 comments

McGraw Hill Expands Its AI-Powered ALEKS Product Portfolio

Market reaction Comment Full text

IHUMAN INC. (IH)

  • Business News
  • June 29, 2026, 12:54 UTC
  • 3
  • 1 comments

iHuman Inc. Announces First Quarter 2026 Unaudited Financial Results

Market reaction Comment Full text

ISROTEL LTD. (ISRO)

  • Business News
  • June 29, 2026, 12:47 UTC
  • 3
  • 1 comments

All the suspending conditions were fulfilled for the sale of the remaining shares (50%) in Tzafon HaYarkon Tel Aviv Ltd.

Market reaction Comment Full text

Anixa Biosciences Inc. (ANIX)

  • Business News
  • June 29, 2026, 12:45 UTC
  • 2
  • 1 comments

Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040

Market reaction Comment Full text

MARRIOTT VACATIONS WORLDWIDE CORP (VAC)

  • Business News
  • June 29, 2026, 12:45 UTC
  • 2
  • 1 comments

The Marriott Vacation Clubs Launches Inner Circle, New Platform Redefining Owner Experiences

Market reaction Comment Full text

Artelo Biosciences Inc. (ARTLW)

  • Business News
  • June 29, 2026, 12:45 UTC
  • 2
  • 1 comments

Artelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026

Market reaction Comment Full text

AKARI THERAPEUTICS PLC (AKTX)

  • Business News
  • June 29, 2026, 12:45 UTC
  • 2
  • 1 comments

Akari Therapeutics Completes Previously Announced PIPE, Strengthening Balance Sheet Ahead of Potential Key Clinical and Regulatory Milestones

Market reaction Comment Full text

ARTELO BIOSCIENCES, INC. (ARTL)

  • Business News
  • June 29, 2026, 12:45 UTC
  • 2
  • 1 comments

Artelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026

Market reaction Comment Full text
  • Previous
  • 3789
  • 3790
  • 3791
  • 3792
  • 3793
  • Next

Search

News categories

  • Technical Exchange News(14694)
  • Event(6229)
  • SEC News(393624)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(239514)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin